INS and diabetes mellitus: Intermediate-term (1- and 3-year) mortality was higher in the insulin-treated DM group compared with the non insulin-treated DM group, but did not reach statistical significance: 12.7% vs. 7.2% (p = 0.269) and 16.4% vs. 11.3% (p = 0.412) respectively.